A robust, sensitive assay for genomic uracil determination by LC/MS/MS reveals lower levels than previously reported  by Galashevskaya, Anastasia et al.
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Considerable  progress  has  been  made  in  understanding  the  origins  of genomic  uracil  and  its role  in
genome  stability  and  host  defense;  however,  the  main  question  concerning  the  basal  level  of  uracil  in
DNA  remains  disputed.  Results  from  assays  designed  to quantify  genomic  uracil  vary  by  almost  three
orders  of  magnitude.  To  address  the  issues  leading  to  this  inconsistency,  we  explored  possible  short-
comings  with  existing  methods  and  developed  a sensitive  LC/MS/MS-based  method  for  the  absolute
quantiﬁcation  of  genomic  2′-deoxyuridine  (dUrd).  To this  end,  DNA  was enzymatically  hydrolyzed  to
2′-deoxyribonucleosides  and  dUrd  was  puriﬁed  in  a preparative  HPLC  step  and  analyzed  by LC/MS/MS.
The  standard  curve  was  linear  over  four  orders  of  magnitude  with  a quantiﬁcation  limit of 5  fmol  dUrd.
Control  samples  demonstrated  high  inter-experimental  accuracy  (94.3%)  and  precision  (CV  9.7%).  An
alternative  method  that employed  UNG2  to excise  uracil  from  DNA  for LC/MS/MS  analysis  gave  similar
+/+daptive  immunity
ctivation-induced cytidine deaminase
results,  but  the  intra-assay  variability  was  signiﬁcantly  greater.  We  quantiﬁed  genomic  dUrd  in  Ung
and  Ung−/− mouse  embryonic  ﬁbroblasts  and human  lymphoblastoid  cell lines  carrying  UNG mutations.
DNA-dUrd  is 5-fold  higher  in  Ung−/− than  in Ung+/+ ﬁbroblasts  and  11-fold  higher  in UNG2  dysfunctional
than  in UNG2  functional  lymphoblastoid  cells.  We  report  approximately  400–600  dUrd  per human  or
murine  genome  in repair-proﬁcient  cells,  which  is  lower  than  results  using  other  methods  and  suggests
s  maythat  genomic  uracil  level
. Introduction
Deamination of 2′-deoxycytidine (dCyd) and misincorpora-
ion of 2′-deoxyuridine 5′-monophosphate (dUMP) are the major
ources of 2′-deoxyuridine (dUrd)/uracil (U) in the mammalian
enome [1]. The former creates U:G mismatches and occurs spon-
aneously, mainly via direct nucleophilic attack of the hydroxyl ion
n the protonated base under physiological conditions, by exposure
o various chemicals, or enzymatically by activation induced cyti-
ine deaminase (AID), APOBEC1, and possibly other members in the
POBEC family [2,3]. Unrepaired U:G mismatches result in C to T
ransitions during replication, the most frequent type of mutation
Abbreviations: LC/MS/MS, liquid chromatography coupled to tandem mass spec-
rometry; UNG, uracil-DNA glycosylase encoded by the UNG-gene; dCyd/dUrd/Dn,
′-deoxycytidine/2′-deoxyuridine/2′-deoxyribonucleoside.
∗ Corresponding author. Tel.: +47 72573074; fax: +47 72576400.
E-mail  address: hans.krokan@ntnu.no (H.E. Krokan).
1 Joint ﬁrst authors.
568-7864 © 2013 The Authors. Published by Elsevier B.V. 
ttp://dx.doi.org/10.1016/j.dnarep.2013.05.002
Open access under CC BY license. have  previously  been  overestimated.
© 2013 The Authors. Published by Elsevier B.V. 
in human cancers [4]. Alternatively, dUMP misincorporation cre-
ates U:A pairs, depends on the dTTP/dUTP ratio at the time of DNA
replication, and is governed by thymidylate synthase and dUTPase
activities [5]. U:A pairs may  be cytotoxic due to altered binding of
transcription factors and indirectly mutagenic through generation
of abasic sites [6–9].
Genomic  dUrd is generally treated as a lesion that can be cor-
rected by base excision repair with mismatch repair as a likely
backup for U:G mismatches [1,10,11]. Nevertheless, dUrd is also
a key intermediate in adaptive immunity. In this process, dUrd
is generated by AID-mediated dCyd deamination, which targets
variable and switch regions of immunoglobulin genes in B-cells
during somatic hypermutation (SHM) and class switch recombi-
nation (CSR), respectively [12]. This is a risky process because
off-target deamination may  cause mutations and translocations,
ultimately culminating in B-cell lymphomas [13–15]. Importantly,
the translocations occur at the DNA damage sites [16]. Furthermore,
infection- and/or inﬂammatory cytokine-driven AID expression
may contribute to carcinogenesis in epithelial cells [17–19].
Open access under CC BY license.The  emerging signiﬁcance of genomic uracil thus calls for an
accurate and reliable method for its quantiﬁcation. Most estab-
lished methods are relative, which precludes comparisons between
experimental batches and different laboratories [6,12,20–25].
7 NA R
D
a
d
e
[
v
4
g
b
t
a
r
r
s
A
t
t
ﬁ
f
g
c
u
2
2
d
P
D
U
t
(
[
(
2
w
w
p
B
v
g
e
i
h
s
2
2
N
R
G
(
b
7
i
(
c
G00 A. Galashevskaya et al. / D
irect quantiﬁcation of absolute levels of genomic uracil can be
chieved using mass spectrometry. There are two main approaches:
etection of U excised from DNA by UNG and detection of dUrd after
nzymatic hydrolysis of DNA to 2′-deoxyribonucleosides (dNs)
26–32]. Both strategies are seemingly straightforward, but a wide
ariation in estimates has been reported, ranging from 3 × 103 to
 × 106 uracils per mammalian genome [31,33]. It has been sug-
ested that the inconsistency in reported genomic uracil levels may
e due to differences in sample type, but may  also emanate from
echnical shortcomings of the employed methods [33].
Here  we present an improved LC/MS/MS-based method for the
bsolute quantiﬁcation of dUrd in DNA and discuss drawbacks of
elated methods. We  explore the issues that may  lead to inaccu-
ate estimation of genomic U and ameliorate them by introducing
teps for specimen clean-up and chromatographic modiﬁcations.
dditionally, we compare dUrd quantiﬁcation by DNA hydrolysis
o U quantiﬁcation by UNG excision. We  lastly applied our method
o quantify genomic dUrd in Ung+/+ and Ung−/− mouse embryonic
broblasts, as well as human lymphoblastoid cell lines derived
rom hyper-IgM patients carrying UNG mutations. We  measured
enomic uracil values lower than those previously reported, indi-
ating that previous methods may  have overestimated genomic
racil.
. Material and methods
.1.  Reagents
2′-Deoxyuridine, 2′-deoxycytidine, 2′-deoxyadenosine, 2′-
eoxyguanosine, thymidine, alkaline phosphatase, nuclease
1, and BSA were from Sigma–Aldrich (Steinheim, Germany);
Nase I was from Roche Applied Science (Mannheim, Germany);
ltraPureTM salmon sperm DNA was from Invitrogen Corpora-
ion (Carlsbad, CA, USA). Recombinant uracil-DNA glycosylase
UNG84) was puriﬁed in-house as previously described [34].
2-13C;1,3-15N2]-2′-deoxyuridine was from C/D/N Isotopes
Pointe-Claire, Quebec, Canada).
.2. Cell lines
Ung+/+ and Ung−/− mouse embryonic ﬁbroblast cell lines [35]
ere cultured in DMEM 4500 mg/l d-glucose, supplemented
ith 0.29 mg/ml  l-glutamine, 10% fetal bovine serum, 100 U/ml
enicillin, 0.1 g/ml streptomycin, and 2.5 /ml  amphotericin
 in a humidiﬁed 5% CO2 incubator at 37 ◦C. Epstein–Barr
irus immortalized human lymphoblastoid cell lines [36], a
ift from Dr. Anne Durandy (Institut National de la Santé
t de la Recherche Médicale, Paris, France), were cultured
n RPMI–1640 + GlutaMaxTM-l medium supplemented with 10%
eat-inactivated bovine serum, 100 U/ml penicillin, 0.1 mg/ml
treptomycin, and 2.5 g/ml amphotericin B.
.3.  DNA isolation and removal of intracellular
′-deoxyribonucleotides
Cells (106/80 l) were lysed in 10 mM Tris-HCl (pH 8.0), 10 mM
aCl, 0.5% SDS, 2.5 mM DTT, 0.25 g/l proteinase K, 0.1 g/l
Nase A and incubated at 37 ◦C for 1 h with shaking at 250 rpm.
enomic DNA was extracted in phenol:chloroform:isoamyl alcohol
25:24:1) and chloroform:isoamyl alcohol (24:1), then precipitated
y adding 0.3 volume equivalents of 10 M ammonium acetate (pH
.9) and one volume equivalent of 100% isopropanol, washed once
n 70% ethanol, and buffered with 100 mM ammonium bicarbonate
pH 7.6) and 1 mM  MgCl2. Where indicated, DNA was isolated from
ell pellets using the DNeasy® Blood and Tissue kit (Qiagen, Hilden,
ermany) according to the manufacturer’s instructions except forepair 12 (2013) 699– 706
increasing the RNase A concentration to 0.1 g/l and decreasing
the temperature during incubation with AL buffer from 56 to
37 ◦C. Potentially co-isolated intracellular 2′-deoxyribonucleotides
were dephosphorylated by incubation with alkaline phosphatase
(pH 7.6) from Escherichia coli (0.2 U/l) in 100 mM ammonium
bicarbonate for 30 min  and DNA precipitated with isopropanol as
described above.
2.4.  DNA hydrolysis to 2′-deoxyribonucleosides
DNA was enzymatically hydrolyzed to dNs. Prior to hydroly-
sis, a control DNA sample was deuracilated by treatment with
UNG to control for uracil generated in vitro during the assay.
To this end, up to 15 g DNA were buffered with 20 mM Tris-
HCl (pH 7.5), 60 mM NaCl, 1 mM DTT, 1 mg/ml  BSA in a reaction
volume of 30 l and treated with 0.075 U UNG84 at 37 ◦C for
1 h. The DNA was isopropanol precipitated as described in 2.3
and resuspended in 30 l 100 mM ammonium acetate (pH 6.0),
10 mM MgCl2, and 1 mM CaCl2 containing 2 U DNase I and 0.2 U
nuclease P1 and incubated for 30 min  at 37 ◦C. As an internal
standard [2-13C;1,3-15N2]-2′-deoxyuridine was used. The sam-
ples were then buffered in ammonium bicarbonate (pH 7.6) to
a ﬁnal concentration of 100 mM,  and incubated for 20 min  at
37 ◦C with 0.1 U alkaline phosphatase from E. coli. To precipi-
tate contaminants that could potentially clog the HPLC column,
three volume equivalents of ice-cold acetonitrile were added to
the samples, which were then centrifuged (16,100 × g, 20 min,
4 ◦C). The supernatants were transferred to new tubes and vac-
uum centrifuged until dry at room temperature. The samples
were ﬁnally dissolved in 100 l water containing 10% acetoni-
trile.
2.5. Preparative puriﬁcation of 2′-deoxyuridine
dUrd was puriﬁed by HPLC prior to LC/MS/MS analysis. The
puriﬁcation was performed using a reverse-phase column with
weak acidic ion-pairing groups (Primesep 200, 2.1 mm × 150 mm,
5 m,  SIELC Technologies, Prospect Heights, IL), kept at 35 ◦C, on
an Agilent 1200 series HPLC system, equipped with a G1365D
multiple wavelength detector (Agilent Technologies, Waldbronn,
Germany). Samples were maintained at 4 ◦C prior to injection.
Each sample was  injected in triplicate with an injection volume
of 30 l. The gradient used consisted of solvent A (water, 0.1%
formic acid) and B (methanol, 0.1% formic acid) starting at 10%
B for 0.5 min, ramping to 60% B over 6 min, holding at 60% B for
4 min, and re-equilibrating with 10% B for 10 min  at a ﬂow rate
of 0.200 ml/min. dNs were quantiﬁed by measuring absorption
at 260 nm.  The fractions containing dUrd and IS were collected
±1 min  with a Foxy R2 fraction collection system (Teledyne ISCO,
Lincoln, NE, USA) and vacuum centrifuged until dry at room tem-
perature. The samples were dissolved in 25 l water containing 5%
methanol.
2.6. Uracil excision
Uracil  was  excised from DNA for direct analysis by LC/MS/MS
to compare uracil excision with DNA hydrolysis as in an alterna-
tive strategy for DNA-uracil quantiﬁcation. The uracil excision and
quantiﬁcation protocol was  modiﬁed from Bulgar et al. [26]. Up  to
15 g DNA were buffered with 20 mM Tris-HCl (pH 7.5), 10 mM
NaCl, 1 mM DTT, 1 mg/ml  BSA in a reaction volume of 40 l and
treated with 0.075 U UNG84 at 37 ◦C for 1 h. The NaCl concen-
tration used was  different from that used for DNA deuracilation
described above to avoid signal loss by ion suppression during
LC/MS/MS. [2-13C,15N2]-Uracil was used as internal standard. After
incubation with UNG, 500 l ice-cold acetonitrile were added to the
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amples and they were then centrifuged (16,100 × g, 20 min, 4 ◦C).
he supernatants were transferred to new tubes and vacuum cen-
rifuged until dry at room temperature. The samples were ﬁnally
issolved in 40 l 10% 2 mM ammonium formate 90% acetonitrile.
.7. LC/MS/MS instrumentation and conditions
Both dUrd and uracil were quantiﬁed using an LC-20AD HPLC
ystem (Shimadzu Corporation, Kyoto, Japan) coupled to an API
000 triple-quadrupole mass spectrometer (Applied Biosystems,
arlsbad, CA, USA) operated under the multiple reaction monitor-
ng (MRM)  mode.
dUrd  was quantiﬁed using a Zorbax SB-C18 reverse phase
olumn at room temperature (2.1 mm × 150 mm,  3.5 m,  Agi-
ent Technologies, Santa Clara, CA, USA), protected with a Zorbax
eliance guard-column (4.6 mm × 12.5 mm,  Agilent Technologies).
he injection volume was 20 l. The gradient used contained sol-
ent A (water, 0.1% formic acid) and B (methanol, 0.1% formic acid)
tarting at 5% B for 0.5 min, ramping to 90% B over 6 min, holding at
0% B for 1.5 min  and re-equilibrating with 5% B for 5 min  at a ﬂow
ate of 0.300 ml/min. Mass spectrometry detection was performed
sing positive electrospray ionization, monitoring the mass tran-
itions 229.2 → 113.0 and 232.2 → 116.0 for 2′-deoxyuridine and
2-13C,1,3-15N2]-2′-deoxyuridine, respectively.
For the alternative uracil-release method, uracil was quantiﬁed
sing a hydrophobic interaction liquid chromatography column
2.1 mm × 100 mm,  3.5 m,  Atlantis HILIC Silica column, Waters
orporation, Milford, MA,  USA). The injection volume was 10 l
nd the HPLC was run at 0.200 ml/min isocratically with 95%
cetonitrile and 5% 2 mM ammonium formate. Detection was  per-
ormed using negative electrospray ionization, monitoring the
ass transitions 110.9 → 41.9 and 114.1 → 43.9 for uracil and [2-
3C,1,3-15N2]-uracil, respectively.
ig. 1. Optimized LC/MS/MS conditions ensure method speciﬁcity. (A) MS/MS spectra of 2
arent [MH]+ to product ion transitions. The proposed origins of key fragments are in
ragments to demonstrate the fragmentation pattern of dUrd. The ﬁnal settings were o
tep  with PrimeSep 200 and standard reverse phase C18 columns on LC/MS/MS chromat
ifferent  y-axis scale. In the lower panel, the range to 1.5 × 104 has been expanded to vis
18  column for pre-HPLC. The dUrd peak is obscured by the [13C]-dCyd peak tail in the
rimesep 200 (solid blue line) columns overcome dUrd peak obfuscation by the [13C]-dCy
C/MS/MS step as well as a higher dUrd peak, probably due to dCyd deamination.pair 12 (2013) 699– 706 701
3. Results
3.1. Method development
3.1.1.  MS/MS analysis
We  used tandem mass spectrometry to validate our method’s
speciﬁcity. MS/MS  spectra revealed ions with m/z  values of 113.0
and 116.0, which correspond to the uracil and isotopically labeled
base in the internal standard (IS), respectively. The m/z values 117.0,
99.0, and 81.1 were found in both dUrd and IS and correspond
to 2-deoxyribose and 2-deoxyribose without one or two water
molecules, respectively (Fig. 1A).
3.1.2. A precursory HPLC step is essential for sample purity
The  analysis of dUrd is complicated by naturally occurring
[13C]-2′-deoxycytidine ([13C]-dCyd), which is isobaric with dUrd.
Although dUrd and dCyd are apparently well separated by reverse-
phase chromatography, the relative abundance of dCyd over dUrd
in DNA is so high that the [13C]-dCyd peak tail (∼1.1% of all car-
bon) will obfuscate the dUrd peak, consequently interfering with
the subsequent MS  analysis. To circumvent this problem, we  used
a reverse-phase column with embedded weak acidic ion-pairing
groups (hereafter referred to by its brand name, Primesep 200),
with which dUrd elutes well before dCyd (Fig. 1B). However, dUrd
is weakly retained in the column and elutes near or with the
void volume, resulting in ion suppression from ions present in
the reaction buffer, which compete for ionization with the ana-
lyte of interest (dUrd, data not shown). To avoid this, we  employed
a precursory HPLC step with a Primesep 200 column to rid the
samples of dCyd and increase sensitivity and then analyzed the
dUrd concentration with a reverse-phase C18 column coupled
to a mass spectrometer. We  also tested a standard C18 column
for the precursory HPLC step, but found that enough dCyd co-
eluted with the dUrd fraction that dCyd deamination occurred
′-deoxyuridine (m/z 229) and [2-13C,1,3-15N]-2′-deoxyuridine (m/z 232.1) showing
dicated. Note that the collision energy was  tuned to acquire spectra with more
ptimized for the speciﬁc mass transitions analyzed. (B) Effect of precursory HPLC
ograms. Note that both chromatograms represent the same data displayed with a
ualize chromatographic tailing and the problems related to [13C]-dCyd when using
 absence of fractionation (dashed red line). Using both C18 (solid black line) and
d peak, but the C18 column retains some dCyd, leading to a [13C]-dCyd peak in the
702 A. Galashevskaya et al. / DNA R
Table  1
Summary of statistics for method validation. Deuracilated salmon sperm DNA
samples were spiked with 5, 15, and 100 fmol dUrd to determine accuracy and
intra/inter-day precision.
dUrd spike
(fmol)
Accuracy (%
theoretical value)
Intra-day
precision (CV %)
Inter-day
precision (CV %)
5 94.0 13.6 15.0
15 97.0 13.1 12.4
100 91.9 2.6 2.6
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n 18 6 18
etween the precursory HPLC step and the LC/MS/MS analysis
Fig. 1B).
An  additional advantage of employing a precursory HPLC step is
hat it provides a convenient opportunity to quantify all dNs prior
o LC/MS/MS analysis, thereby allowing accurate quantiﬁcation of
Urd per dNs. We  compared the DNA concentration measured by
pectrophotometry of 5 g salmon sperm DNA with the calculated
oncentration by HPLC-UV on three separate days and found 99.9%
ecovery after hydrolysis with a CV of 8.34%.
.1.3. Determination of range, linearity, detection limit, precision,
nd accuracy
We  determined the range, linearity, and detection limit for
Urd quantiﬁcations by making standard curves in both water and
euracilated DNA. Triplicate standard curves of dUrd in water con-
aining 5–200 fmol dUrd and 40 fmol IS were analyzed on three
ifferent days (r2 = 1.0000), demonstrating near perfect linearity
Supplementary Fig. 1). Deuracilated DNA prepared by UNG-
reatment and isopropanol precipitation of 5 g salmon sperm DNA
as spiked with 5, 15, and 100 fmol dUrd and assayed in sets of
ix replicates. The mean observed accuracy for these samples was
4.3%, and the intra- and inter-day CV values were 9.7 and 10%,
espectively. The lower limit of quantiﬁcation was found to be
 fmol dUrd (CV 15% n = 18). The data are summarized in Table 1.
Supplementary  data associated with this article can be
ound, in the online version, at http://dx.doi.org/10.1016/j.dnarep.
013.05.002.
.1.4.  Sample contamination with intracellular
′-deoxyribonucleotides causes overestimation of genomic dUrd
We  tested whether cellular dUMP and dCMP could possibly
nterfere with dUrd analysis due to co-puriﬁcation with DNA.
mportantly, dCMP and dCyd (as well as dCyd in ssDNA) are deam-
nated more than two orders of magnitude faster than dCyd in
sDNA [3]. To this end, we pre-treated DNA samples with alkaline
hosphatase and then precipitated the DNA. Our hypothesis was
hat dUMP and dCMP would co-purify with DNA to a larger extent
han dUrd. Indeed, we found that up to 98% of measured dUrd in
ommercially prepared DNA was removed after phosphatase treat-
ent and precipitation (Fig. 2A). DNA isolated in our laboratory
howed similar results (data not shown).
.1.5. Overcoming dCyd deamination during sample work-up
Three  main factors have been demonstrated to affect cytosine
eamination in puriﬁed DNA samples: temperature, pH, and the
egree to which DNA is denatured [3,37,38]. Taking this into con-
ideration, we made efforts to minimize dCyd deamination during
ample work-up and analysis. Several methods used by other
aboratories involve heat-denaturation of DNA prior to enzymatic
ydrolysis [27]. We  found that DNA denaturation by heating to
5 ◦C for 5–20 min  increases the dUrd signal approximately 1.7-
nd 2.7-fold, respectively (Fig. 2B). To avoid deamination during
ork-up and analyses, we optimized reaction time and buffer
onditions, concluding with enzymatic hydrolysis at pH 6–7.6epair 12 (2013) 699– 706
and  37 ◦C for 50 min  using DNase I, nuclease P1, and alkaline
phosphatase. To test the rate at which dUrd is introduced under
these reaction conditions, we assayed the amount of dUrd gen-
erated during sample analysis over time. We  found a constant
deamination rate of 4.805 × 10−3 ± 5.9 × 10−5 dUrd/106 bp/min
(R2 = 0.9964, n = 12, Fig. 2C). This corresponds to 1.059 × 10−2
dUrd/106 dCyd/min, which is in line with previously reported
values of dCyd deamination rates of 2.6 × 10−2, 1.2 × 10−3,
and 4.8 × 10−5 dUrd/106 dCyd/min for deoxyribonucleosides,
single-stranded DNA, and double-stranded DNA, respectively
[3]. Subtracting the deuracilated DNA control from the normal
samples yielded a constant value regardless of the time point (0.66
dUrd/106 bp); however, the variation between replicate experi-
ments increased with reaction time due to increasing background.
Thus, we included a deuracilated DNA control in all sample batches
to control for in vitro-generated dUrd.
It has been reported that alkaline phosphatase contained mea-
surable dCyd deaminase activity [28,29]. We  substituted dCyd for
DNA to the equivalent of ∼2 g (10.5 nmol) and carried out mock
hydrolysis with all enzymes, only alkaline phosphatase, and no
enzymes. The amount of dUrd per dCyd in the untreated samples
was statistically indistinguishable from that of the samples con-
taining either all enzymes or only alkaline phosphatase (data not
shown), which strongly suggests that none of the enzyme prepa-
rations employed contained dCyd deaminase activity under our
reaction conditions. We  therefore did not employ dCyd deaminase
inhibitors.
3.1.6. dUrd quantiﬁcation by DNA hydrolysis is more robust than
U  quantiﬁcation by U excision
Several groups have employed UNG to excise uracil for GC
or LC/MS analysis [26,32]. To compare this strategy to the dUrd
method, we  used UNG to excise U from DNA and measured U
by a hydrophobic interaction chromatography column coupled to
the same mass spectrometer used for dUrd quantiﬁcation. First,
we spiked U into deuracilated DNA and determined that the limit
of quantiﬁcation for this assay was 5 fmol. Then, we measured
genomic U in DNA that had been heated to 95 ◦C. The results
were similar to those obtained by DNA hydrolysis (Fig. 2B). We
also assayed genomic uracil using both the DNA hydrolysis and U
excision on DNA isolated using either phenol:chloroform:isoamyl
alcohol  isolation or a column-based kit (Supplementary Fig. 2). The
level of genomic dUrd was similar regardless of the DNA isolation
method when assayed using the DNA hydrolysis method, but signif-
icantly different in UNG2 deﬁcient cells when using the U excision
method (P = 0.0275, n = 3). This indicates that DNA hydrolysis is both
more robust and reproducible than the U excision method.
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.dnarep.
2013.05.002.
3.2.  Genomic uracil in human and mouse cells proﬁcient or
deﬁcient  in UNG-activity
We  tested the biological applicability of our method by compar-
ing the levels of genomic dUrd in mammalian cell lines. First, we
compared two lymphoblastoid cell lines: one with UNG-deﬁciency
derived from a patient with a homozygous mutation substituting
Ser with Phe (UNG2-F251S) and one with functional UNG derived
from an individual with a heterozygous mutation substituting Arg
with Cys (UNG2-R88C) [36]. The UNG2-R88C mutation has recently
been reported in the NCBI SNP database (rs151095402) with a
frequency of the C/T heterozygote of 0.003 in a cohort of >1500 indi-
viduals in the NHLBI Exome Sequencing Project. Furthermore, the
UNG2-R88C cell line’s overall uracil excision activity has been mea-
sured and is comparable to that in other UNG-WT human tissues
A. Galashevskaya et al. / DNA Repair 12 (2013) 699– 706 703
Fig. 2. Sample contamination with intracellular 2′-deoxyribonucleotides and in vitro dCyd deamination leads to overestimation of genomic dUrd. (A) Alkaline phosphatase
(AP) pretreatment of commercially prepared DNA followed by repeated isopropanol precipitation steps prior to DNA hydrolysis decreases the ﬁnal genomic dUrd value.
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as a lesion or as an essential intermediate in antibody afﬁn-
ity maturation. The interplay between these two ﬁelds forms
the link between adaptive immunity and oncogenesis that has
Fig. 3. Quantiﬁcation of genomic dUrd in Ung+/+ and Ung−/− mouse embryonicB)  Denaturation of salmon sperm DNA by heating at 95 ◦C in water induces dCyd
rolongation of sample work-up procedure increases the amount of measured dU
–7.6  and 37 ◦C for 50 min, 6 h, and 9 h. In vitro dCyd deamination occurs at the cons
nd cell lines, whereas the UNG2-F251S is devoid of in vitro uracil
xcision activity [39,40]. We  assayed genomic dUrd in these human
ell lines in three separate experiments and found an 11-fold higher
evel of dUrd per base pair in the UNG2-F251S line (1.10 ± 0.13
Urd/106 bp, CV 11.6%), as compared with the UNG2-R88 C line
0.105 ± 0.014 dUrd/106 bp, CV 13%) (Fig. 3A).
We also quantiﬁed genomic dUrd in Ung-proﬁcient and
ng-deﬁcient mouse embryonic ﬁbroblasts (MEFs) in triplicate
xperiments (Fig. 3B). We  found a 5-fold higher genomic dUrd level
n the Ung−/− line (0.344 ± 0.023 dUrd/106 bp, CV 6.76%) as com-
ared with the Ung+/+ line (0.072 ± 0.006 dUrd/106 bp, CV 8.59%).
hese experiments also suggest that other uracil-DNA glycosylases
e.g. SMUG1, TDG, and MBD4 [1]) cannot compensate for the lack
f uracil-DNA glycosylase activity in the absence of UNG2.
.  Discussion
Although great progress has been made in understanding the
echanisms of base excision repair, quantitative information on
he genomic content of the DNA base lesions and intermedi-
tes involved has yielded highly divergent results. As examples,
easurements of genomic 8-oxo-7,8-dihydroguanine, uracil, andbasic sites have given results varying by orders of magnitude for
ach lesion [33,41–45].
Here,  we have made efforts to improve quantiﬁcation of
enomic uracil by mass spectrometry and ﬁnd that the content isination and increases genomic dUrd or U content in time-dependent manner. (C)
mon sperm DNA samples as well as deuracilated controls were hydrolyzed at pH
ate of 4.805 × 10−3 dUrd/106 bp/min. Results represent triplicate experiments ±SD.
lower than previously reported. Accurate quantiﬁcation of genomic
uracil is important to understand its processing, whether presentﬁbroblasts  and human lymphoblastoid cell lines carrying UNG mutations. (A) UNG2
dysfunctional lymphoblastoid cells (UNG2-F251S) had 11-fold higher genomic dUrd
level than lymphoblastoid cells with functional UNG2 (UNG2-R88 C). (B) Genomic
dUrd  level was 5-fold higher in Ung−/− than in Ung+/+mouse embryonic ﬁbroblasts.
Results  represent triplicate experiments ±SD.
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Fig. 4. Overview of possible errors in the methods for absolute quantiﬁcation of
genomic U/dUrd. (A) Intracellular 2′-deoxyribonucleotides can co-elute with DNA
and be subsequently included in quantiﬁcation. (B) Unspeciﬁc contaminants are
usually more abundant with decreasing molecular weight of the precursor ions.
(C) Differential derivatization of standards versus samples may  lead to inaccuracies,
and  the efﬁciency of derivatization is not controlled. (D) Inaccurate determination of
DNA concentration may  compromise quantiﬁcation. The extent of the uracil excision
reaction is not monitored. (E) Denaturation of DNA by heating to 95 ◦C deaminates
dCyd  and overestimates the ﬁnal genomic dUrd measurement. (F) Deamination of
dCyd occurs at 37 ◦C and neutral pH. Extended incubation time during sample work-
up may  artiﬁcially increase the amount of dUrd. (G) dCyd elutes before dUrd with
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Fig. 5. Summary of improved genomic dUrd quantiﬁcation. DNA isolation is
improved by avoiding sample heating at 56 ◦C. A phosphatase pre-treatment step
removes intracellular dCMP and dUMP, which otherwise co-purify with DNA. UNG2
is used to deuracilate DNA as a control processed in parallel to estimate whether
and  how much dUrd is generated during the analysis. DNA hydrolysis to dNs by
nuclease/phosphatase treatment is kept short and pH neutral. A precursory HPLC
of a normal reverse-phase column for precursory HPLC fraction-everse-phase chromatography and may  therefore contaminate the dUrd fraction
ue to peak tailing. dCyd may  then be deaminated prior to MS/MS analysis.
ecently been established [13,15]. In this sense, relative quantiﬁ-
ation of genomic uracil can be useful and in some cases preferable
o absolute quantiﬁcation. For instance, several assays are DNA
equence-speciﬁc and can therefore shed light on speciﬁc AID
ff-target effects [12,22]. Nevertheless, relative assays hamper
omparison between data sets, and sequence-speciﬁc assays are
iased to the sequences they target. Indeed, the wide range of
eported values for genomic uracil suggests that reliable quan-
iﬁcation of genomic uracil (as free uracil or dUrd) is technically
roblematic [31,33]. Therefore, all steps from cell lysis through
NA isolation and analysis should be standardized and validated.
 schematic visualization of the different approaches to genomic
racil and dUrd analyses and steps at which errors may  arise is pre-
ented in Fig. 4. The DNA isolation step can be a signiﬁcant error
ource (Fig. 4A). We  noticed that isopropanol precipitation steps
educed the amount of measured dUrd regardless of how DNA was
solated. Adding alkaline phosphatase prior to precipitation further
ecreased the dUrd signal, presumably by removing intracellular
ucleotides (speciﬁcally dUMP and dCMP) co-purifying with DNA.
As an alternative to DNA hydrolysis and quantiﬁcation of dUrd,
racil can be excised using uracil-DNA glycosylase and directly ana-
yzed by MS/MS  (Fig. 4B) [30,31]. Uracil is inherently more prone to
ackground signal in MS/MS  because it is a heterocyclic molecule
hat resonates between non-aromatic amide and aromatic imide
automers, the chemical bonds in which require more energy to
reak than the N-glycosylic bond between U and the deoxyribose
n dUrd. Consequently, the additional collision energy required to
reak up the uracil molecule results in a higher probability of mis-
aking contaminants for the analyte. In this sense, quantiﬁcation
f dUrd is advantageous to measuring U because the abundance
f interfering components is lower. Derivatizating U abrogates this
ffect, but adds complexity because the degree to which U has been
erivatized cannot easily be monitored. In addition, it has proven
ifﬁcult to establish robust conditions for derivatization to the
xtent that different conditions have been required to derivatizestep efﬁciently removes dCyd from the sample. Together, it signiﬁcantly improves
the  accuracy of the method.
biological samples and standards (Fig. 4C) [32]. Derivatization can
be circumvented by employing hydrophilic interaction chromatog-
raphy (Fig. 4D) [26]. We tested a similar method and found the
sensitivity comparable to measuring dUrd by hydrolysis; however,
intra-sample variability was greater. Indeed, we compared DNA
samples isolated using different methods and found no variability
between DNA isolation methods when employing DNA hydrolysis,
whereas there was signiﬁcant difference using the U excision assay.
This may  result from our inability to gauge the extent of the U exci-
sion under these assay conditions, as well as imprecise estimation
of the DNA concentration. In contrast, the present DNA hydrolysis
method normalizes samples to the amount of dNs measured spec-
trophotometrically during the precursory HPLC step, which both
determines the extent to which DNA has undergone hydrolysis
and provides very accurate determination of DNA concentration.
We performed hydrolysis with 5, 10, 15, and 20 g DNA and saw
no variation in dUrd measurements (data not shown). Moreover,
samples are minimally handled between precursory HPLC and
analytical LC/MS/MS, resulting in better reproducibility. Uracil exci-
sion is not necessarily inferior to DNA hydrolysis as a DNA-uracil
quantiﬁcation method and its shortcomings may  theoretically be
ameliorated by meticulous standardization of sample treatment,
but it is nevertheless more susceptible to intra-lab or intra-sample
variations.
Employing DNA hydrolysis to measure genomic dUrd has been
reported previously [27–29]; however, the methods reported
are prone to overestimation of genomic dUrd content for var-
ious reasons. DNA heat denaturation causes dCyd deamination
and therefore overestimates dUrd estimates several-fold (Fig. 4E)
[27]. The dCyd-containing products deaminate orders of mag-
nitude faster than double-stranded DNA during long incubation
times (6–9 h at 37 ◦C) required for complete enzymatic hydroly-
sis (Fig. 4F). We  optimized experimental conditions to only require
50 min  incubation at 37 ◦C. Decreasing this incubation time further
would potentially yield more accurate results. Finally, employmentation of dNs with which dUrd elutes after dCyd results in a risk of
dCyd contamination in the dUrd fraction from peak tailing because
dCyd is so much more abundant than dUrd (Fig. 4G) [28]. The dCyd
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ontamination is problematic both because [13C]-dCyd is isobaric
ith dUrd and because dCyd may  deaminate to dUrd between
teps. To avoid that problem, we employed a reverse-phase col-
mn with weak acidic ion-pairing groups with which dUrd elutes
efore dCyd. The precursory HPLC step may  be omitted by com-
ining the PrimeSep200 and C18 columns with a column switcher.
 dual-column system would shorten the total analysis time and
ecrease the likelihood of dUrd contamination as a result of sample
andling before LC/MS/MS analysis; however, the accuracy of the
ssay would not necessarily increase. An overview of our improved
ethod is presented in Fig. 5.
We used the optimized conditions to measure dUrd in DNA
solated from Ung+/+ and Ung−/− mouse embryonic ﬁbroblasts
nd human lymphoblastoid cell lines derived from hyper-IgM
atients carrying UNG mutations. The values reported for genomic
racil here were lower than those reported by other groups,
pproximately 400–600 dUrd per human or murine genome in
epair-proﬁcient cells [31]. Although this alone does not prove that
ur method is superior to those previously published, our demon-
tration of overestimation sources indicates that our method is
robably more reliable.
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